You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Cutaneous T-Cell Lymphoma (CTLC)

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Persistent or Recurrent Cutaneous T-Cell Lymphoma Trial in Australia, Puerto Rico, United States (E7777 9 mcg/kg)

Completed
  • Persistent or Recurrent Cutaneous T-Cell Lymphoma
  • E7777 9 mcg/kg
  • Birmingham, Alabama
  • +21 more
Dec 5, 2022

Lymphoma, T-Cell, Cutaneous, Mycosis Fungoides/Sezary Syndrome Trial in Madrid, Zürich (Atezolizumab)

Active, not recruiting
  • Lymphoma, T-Cell, Cutaneous
  • Mycosis Fungoides/Sezary Syndrome
  • Madrid, Spain
  • +1 more
Jul 1, 2022

Cutaneous T-Cell Lymphoma, Mature T-cell Malignancies, Peripheral T-Cell Lymphoma Trial run by the NCI (Romidepsin,

Recruiting
  • Cutaneous T-Cell Lymphoma
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 23, 2023

Early Stage Mycosis Fungoides Cutaneous T Cell Lymphoma (MF-CTCL) (Stage IA-IB) Trial in Bordeaux, Paris (chlormethine gel)

Recruiting
  • Early Stage Mycosis Fungoides Cutaneous T Cell Lymphoma (MF-CTCL) (Stage IA-IB)
  • chlormethine gel
  • Bordeaux, France
  • +1 more
Aug 17, 2022

T-Cell Lymphoma, Peripheral T-Cell Lymphoma Refractory, Cutaneous T-Cell Lymphoma Refractory Trial in United States (LB1901)

Active, not recruiting
  • T-Cell Lymphoma
  • +4 more
  • LB1901
  • Rochester, Minnesota
  • +3 more
Feb 15, 2022

Skin Barrier and Microbiome of CTCL Patients

Not yet recruiting
  • Lymphoma, T-Cell, Cutaneous
    • Leiden, Netherlands
      Centre for Human Drug Research
    Apr 21, 2023

    T-Cell Non-Hodgkin Lymphoma, Acute Myeloid Leukemia, Angioimmunoblastic T-cell Lymphoma Trial in Saint Louis (WU-CART-007)

    Not yet recruiting
    • T-Cell Non-Hodgkin Lymphoma
    • +14 more
    • WU-CART-007
    • Saint Louis, Missouri
      Washington University School of Medicine
    Jan 17, 2023

    Quality of Life in Cutaneous Lymphoma Patients Using Skindex29

    Not yet recruiting
    • Cutaneous Lymphoma
    • Quality-of-Life Assessment
    • Questionnaire Administration
    • Duarte, California
      City of Hope Medical Center
    Aug 23, 2022

    Peripheral T Cell Lymphoma (PTCL), Cell Therapy Trial in United States (MT-101, MT-101 + Conditioning (Lymphodepleting)

    Recruiting
    • Lymphoma, T-Cell, Peripheral
    • +4 more
    • MT-101
    • MT-101 + Conditioning (Lymphodepleting) Chemotherapy
    • Duarte, California
    • +8 more
    Jan 27, 2023

    Cutaneous T Cell Lymphoma, Mycosis Fungoides Trial (Hypericin, Visible Light)

    Not yet recruiting
    • Cutaneous T Cell Lymphoma
    • Mycosis Fungoides
    • (no location specified)
    May 23, 2023

    Extranodal NK T Cell Lymphoma, NK-Cell Leukemia Trial in Xuzhou (Anti-CD56 CAR T)

    Recruiting
    • Extranodal NK T Cell Lymphoma
    • NK-Cell Leukemia
    • Anti-CD56 CAR T
    • Xuzhou, Jiangsu, China
      The Affiliated Hospital of Xuzhou Medical University
    Jul 10, 2023

    Response to Gemcitabine Chemotherapy in Mycosis Fungoides

    Recruiting
    • Lymphoma, T-Cell, Cutaneous
    • Mycosis Fungoides
    • single-arm, non-randomized Biodynamic imaging (BDI)
    • Indianapolis, Indiana
      Indiana University School of Medicine, Department of Dermatology
    Nov 16, 2022

    Cutaneous T-cell Lymphoma (CTCL) Trial in Stanford, Chicago, Houston (Sapacitabine)

    Terminated
    • Cutaneous T-cell Lymphoma (CTCL)
    • Stanford, California
    • +2 more
    Dec 7, 2021

    T-cell Lymphoma Trial (CHOP + CD4, CHOP)

    Terminated
    Has Results
    • T-cell Lymphoma
    • (no location specified)
    May 2, 2022

    Diagnostic Classifier for Cutaneous T-cell Lymphomas

    Recruiting
    • CTCL/ Mycosis Fungoides
    • Skin suction blistering and skin biopsies
    • Vienna, Austria
      Medical University of Vienna
    Apr 4, 2022

    Cutaneous T Cell Lymphoma, Mycosis Fungoides Trial (Mogamulizumab, Brentuximab vedotin)

    Not yet recruiting
    • Cutaneous T Cell Lymphoma
    • Mycosis Fungoides
    • (no location specified)
    Dec 7, 2022

    Peripheral T Cell Lymphoma, Relapsed Peripheral T-Cell Lymphoma, Refractory T-Cell Lymphoma Trial in Xiamen (Chidamide combined

    Recruiting
    • Peripheral T Cell Lymphoma
    • +2 more
    • Chidamide combined with Duvillisib
    • Xiamen, Fujian, China
      The First Affiliated Hosptial of Xiamen University
    Nov 28, 2023

    ASCT Versus Chemotherapy as First-Line Consolidation Therapy

    Completed
    • T-cell Lymphoma Adults
    • consolidation with ASCT
    • (no location specified)
    Nov 25, 2023

    Advanced Cancer, Gastric Cancer, Breast Cancer Trial in United States (GZ17-6.02, Capecitabine)

    Active, not recruiting
    • Advanced Cancer
    • +16 more
    • Scottsdale, Arizona
    • +3 more
    Dec 22, 2022

    Benefit of Allogeneic Haematopoietic Stem Cells in Cutaneous

    Active, not recruiting
    • Epidermotropic T-cell Lymphomas
    • HSCT
    • Standard Care
    • Paris, France
      Saint Louis hospital
    Apr 15, 2022

    Cutaneous T-Cell Lymphoma/Mycosis Fungoides Trial in Fairport (Hypericin, Mechlorethamine Topical Gel)

    Not yet recruiting
    • Cutaneous T-Cell Lymphoma/Mycosis Fungoides
    • Fairport, New York
      Rochester Skin Lymphoma Medical Group
    Nov 20, 2023

    T Cell Lymphoma Trial in New Haven (Mogamulizumab, DA-EPOCH Protocol)

    Not yet recruiting
    • T Cell Lymphoma
    • New Haven, Connecticut
      Yale Smilow Cancer Hospital
    Aug 14, 2023

    Characterization of the Microbiome in Cutaneous T Cell Lymphoma

    Recruiting
    • Cutaneous T Cell Lymphoma
      • Chicago, Illinois
        Northwestern University
      Oct 2, 2021

      Peripheral T-Cell Lymphoma, Not Otherwise Specified, Angioimmunoblastic T-cell Lymphoma Trial in Changchun (Rituximab,

      Recruiting
      • Peripheral T-Cell Lymphoma, Not Otherwise Specified
      • Angioimmunoblastic T-cell Lymphoma
      • Changchun, Jilin, China
        The First Bethune Hospital of Jilin University
      Apr 7, 2023

      T-Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma Trial (CD7-CART01)

      Not yet recruiting
      • T-Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma
      • CD7-CART01
      • (no location specified)
      Sep 26, 2023